Latest News

Determining Dose-Limiting Toxicity in Patients with Oesophagogastric Cancer

Determining Dose-Limiting Toxicity in Patients with Oesophagogastric Cancer

Sarcopenia is a predictor of dose-limiting toxicity in patients with oesophagogastric cancer who are receiving neo-adjuvant chemotherapy.

Association Between Cabozantinib and Skin Reactions in Patients with Urothelial Carcinoma

Association Between Cabozantinib and Skin Reactions in Patients with Urothelial Carcinoma

Researchers set out to better understand the relationship and frequency skin reactions in patients with urothelial carcinoma who are being treated only cabozantinib.

Non-NK1 Receptor Antagonists Effective Against Chemotherapy-Induced Nausea and Vomiting

Non-NK1 Receptor Antagonists Effective Against Chemotherapy-Induced Nausea and Vomiting

Researchers examine the effects of a combination of adjunctive NK1RA drugs with 5-HT3 antagonists on adult cancer patients who were administered moderate- or highly emetogenic chemotherapy.

Younger Patients With a History of Skin Cancer Who Smoke Are More Likely to Develop Extra-Cutaneous Cancers

Younger Patients With a History of Skin Cancer Who Smoke Are More Likely to Develop Extra-Cutaneous Cancers

In this study, researchers sought to determine whether a history of nonmelanoma skin cancer (NMSC) and/or melanoma is associated with extracutaneous cancers.

Can Carvedilol Prevent Skin Cancer?

Can Carvedilol Prevent Skin Cancer?

The β-blocker, carvedilol may have the potential to be used as a chemoprevention agent against skin cancer and β-ARs may serve as a novel target for cancer prevention.

For EGFR-Mutant Non-Squamous Non-Small Cell Lung Cancer, Bevacizumab Plus Chemotherapy Not Effective After TKIs

For EGFR-Mutant Non-Squamous Non-Small Cell Lung Cancer, Bevacizumab Plus Chemotherapy Not Effective After TKIs

Bevacizumab, paclitaxel, and carboplatin did not achieve the prespecified objective response rate goal for the treatment of patients with EGFR-mutant non-squamous NSCLC who have failed prior EGFR TKI therapy.

For Melanoma, Pretreatment Influences Vemurafenib Therapy Outcomes

For Melanoma, Pretreatment Influences Vemurafenib Therapy Outcomes

Researchers have found that the type of pretreatment, such as chemotherapy or immunotherapy, greatly influences vemurafenib therapy outcomes for patients with BRAF V600 mutated melanoma.

miniDOX Chemotherapy for Patients with Advanced Gastric Cancer

miniDOX Chemotherapy for Patients with Advanced Gastric Cancer

For patients with advanced gastric cancer, chemotherapy can improve rates of overall survival.

Dose-Adjusted R-EPOCH Provides Long-Term Benefit for High-Risk Large B-Cell Lymphoma

Dose-Adjusted R-EPOCH Provides Long-Term Benefit for High-Risk Large B-Cell Lymphoma

Researchers have found that DA-EPOCH-R showed good long-term benefit and was well tolerated in patients with high-risk large B cell lymphoma.

For Advanced Non-Small Cell Lung Cancer (NSCLC), Nintedanib Improves Overall Survival Without Reducing Quality of Life

For Advanced Non-Small Cell Lung Cancer (NSCLC), Nintedanib Improves Overall Survival Without Reducing Quality of Life

Researchers have found that second-line nintedanib plus docetaxel for the treatment of patients with advanced NSCLC improves overall survival without decreasing quality of life.

Phase I Trial of hTERT DNA Immunotherapy Initiated in Adults with Breast, Lung, and Pancreatic Cancer

Phase I Trial of hTERT DNA Immunotherapy Initiated in Adults with Breast, Lung, and Pancreatic Cancer

High levels of hTERT (human telomerase reverse transcriptase) expression are found in 85% of human cancers, and is therefore a significant target for cancer treatment.

Induction Chemotherapy to Downstage Advanced Oesophageal Cancer Before Surgery

Induction Chemotherapy to Downstage Advanced Oesophageal Cancer Before Surgery

After diagnosis of locoregionally advanced oesophageal tumors or disputable distant metastases, patients receive induction chemotherapy.

Systematic Review Shows Moxibustion Not Superior to Other Therapies for Chemo-Induced Leukopenia

Systematic Review Shows Moxibustion Not Superior to Other Therapies for Chemo-Induced Leukopenia

Researchers have found that moxibustion is not superior to other drug therapy for the treatment of patients with chemotherapy-induced leukopenia

In Patients With Renal Cell Carcinoma Receiving Everolimus, Acute Kidney Injury is Common

In Patients With Renal Cell Carcinoma Receiving Everolimus, Acute Kidney Injury is Common

According to a recent study published in the journal BMC Cancer, everolimus-induced acute kidney injury is a common adverse effect with everolimus treatment in patients with cancer and increased creatinine levels.

Palbociclib Doubles PFS in Women with Advanced Breast Cancer

Palbociclib Doubles PFS in Women with Advanced Breast Cancer

Researchers have found that palbociclib doubled progression-free survival in women with ER-positive, HER2-positive advanced breast cancer compared with those who did not receive the drug.

More News

Health Care Expenditure Slowed in US

Health sector prices explain much of difference between U.S. and other high-spending countries.

States Concerned About Higher-Than-Expected Medicaid Enrollment

Millions signing up for Medicaid to comply with federal health care law.

EHR Use More Than Doubles

Almost 80% of doctors in the United States have switched from paper to electronic health records.

Many Docs Order Unnecessary Medical Tests

Most physicians believe that doctors order too many medical tests, yet half admit to doing so themselves in response to a patient who insists, a new survey shows.

Reducing Six Risk Factors May Prevent 37 Million Deaths

Several modifiable risk factors can cut chronic disease deaths over the next 15 years.

Majority of Women Lack Accurate Knowledge of Their Own Breast Cancer Risk

Caucasian women overestimate their risk of breast cancer while African American and Hispanic women underestimate their risk, according to research presented at BCS 2013.

Survey Identifies Modifiable Barriers to Mammography Screening Among Rural US Women

A survey presented at BCS 2013 has found a number of factors that cause rural US women to avoid breast cancer screening.

Perioperative MRI of Uncertain Benefit for Women with DCIS

The benefit of perioperative MRI for women with ductal carcinoma in situ (DCIS) is "uncertain," found a study presented during BCS 2013.

Dr. Edith Perez's Recommended Abstracts at BCS 2013

ChemotherapyAdvisor.com Editorial Board member Dr. Edith Perez of the Mayo Clinic, Jacksonville, FL, recommends high impact abstracts at the Breast Cancer Symposium 2013.

Radiotherapy for DCIS Is Not Associated With Increased Cardiovascular Disease

Women who underwent radiation for ductal carcinoma in situ do not face an increased risk of cardiovascular disease, found a study presented at BCS 2013.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs